Jamie Ann Chevalier, AUD | |
111 Colchester Ave, Wp4 - Acc, Burlington, VT 05401-1473 | |
(802) 847-4535 | |
(802) 847-8198 |
Full Name | Jamie Ann Chevalier |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | 111 Colchester Ave, Burlington, Vermont |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669782728 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 8046504 (Vermont) | Primary |
Provider Name | University Of Vermont Medical Center Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, has been awarded its first patent for a propriety tissue cleaning and disinfecting process called RICA.
Women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline, suggests a study from researchers at the Johns Hopkins Bloomberg School of Public Health.
Approximately 170,000 people die every year in Europe from the direct consequences of advanced chronic liver disease (cirrhosis).
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
› Verified 1 days ago
Provider Name | Porter Hospital Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1134457013 PECOS PAC ID: 1850365180 Enrollment ID: O20050919000862 |
News Archive
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, has been awarded its first patent for a propriety tissue cleaning and disinfecting process called RICA.
Women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline, suggests a study from researchers at the Johns Hopkins Bloomberg School of Public Health.
Approximately 170,000 people die every year in Europe from the direct consequences of advanced chronic liver disease (cirrhosis).
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jamie Ann Chevalier, AUD 111 Colchester Ave, Wp4 - Acc, Burlington, VT 05401-1473 Ph: (802) 847-4535 | Jamie Ann Chevalier, AUD 111 Colchester Ave, Wp4 - Acc, Burlington, VT 05401-1473 Ph: (802) 847-4535 |
News Archive
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, has been awarded its first patent for a propriety tissue cleaning and disinfecting process called RICA.
Women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline, suggests a study from researchers at the Johns Hopkins Bloomberg School of Public Health.
Approximately 170,000 people die every year in Europe from the direct consequences of advanced chronic liver disease (cirrhosis).
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
› Verified 1 days ago
Mrs. Linda Ann Hazard, MS CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 108 Cherry St, Burlington, VT 05402 Phone: 802-651-1606 Fax: 802-951-1218 | |
Dr. Kathryn E Keyes, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave Dept Of, Burlington, VT 05401 Phone: 802-847-4535 | |
Thomas Peter Townsend, Audiologist Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Ent Wp 4 Acc, Burlington, VT 05401 Phone: 802-847-7381 Fax: 802-847-8198 | |
Sydney S Abernathy, M.S. Audiologist Medicare: Medicare Enrolled Practice Location: 108 Cherry St, Burlington, VT 05401 Phone: 800-537-0076 | |
Elizabeth Adams, MA CCC A Audiologist Medicare: Medicare Enrolled Practice Location: 489 Main Street, University Of Vermont Pomeroy Hall, Burlington, VT 05405 Phone: 802-656-3861 Fax: 802-656-2528 | |
Eleanor M. Luse Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 489 Main St, Pomeroy Hall, Burlington, VT 05405 Phone: 802-656-3861 Fax: 802-656-2528 |